Saba discloses 4.71% stake in Clough Global

Saba Capital Management filed Amendment No. 3 to its Schedule 13D on Clough Global Equity Fund, reporting beneficial ownership of 881,942 common shares, or 4.71% of the fund’s outstanding shares.

Rhea-AI Filing Summary

Saba Capital Management filed Amendment No. 3 to its Schedule 13D on Clough Global Equity Fund, reporting beneficial ownership of 881,942 common shares, or 4.71% of the fund’s outstanding shares. The stake is held with shared voting and shared dispositive power, and no sole voting or dispositive power.

Saba states that approximately $8,818,087 was paid to acquire these shares, using investor subscription proceeds, related capital appreciation, and ordinary-course margin borrowings. The ownership percentage is based on 18,738,120.892 shares outstanding as of May 8, 2026, as disclosed in the fund’s proxy statement. Item 4 (purpose of transaction) is marked not applicable, and all trades listed for this amendment were executed in the open market.

Insights

Closed-end fund activist & governance analyst

Saba reports a 4.71% position in Clough Global with shared control over the stake.

The filing shows Saba Capital and related entities owning 881,942 Clough Global Equity Fund shares, or 4.71% of outstanding, with shared voting and dispositive power. Funding came from investor capital and margin borrowings, which is typical for hedge fund positions.

This is an amendment to an existing Schedule 13D, not a new disclosure of intent. Item 4 lists the purpose of the transaction as not applicable, and there is no description of plans to influence management or strategy. All recent trades tied to this amendment were executed in the open market.

Because the filing does not outline any specific actions or proposals, the market significance depends on how Saba may use this position in the future. Subsequent company or shareholder communications would be needed to understand any strategic implications of this ownership stake.

Key Figures

Shares beneficially owned: 881,942 shares Ownership percentage: 4.71% Shares outstanding: 18,738,120.892 shares +4 more

7 metrics

Shares beneficially owned 881,942 shares Common shares of Clough Global Equity Fund reported by each reporting person

Ownership percentage 4.71% Portion of Clough Global Equity Fund’s outstanding common shares

Shares outstanding 18,738,120.892 shares Common stock outstanding as of May 8, 2026, per DEF 14A

Total cost of position $8,818,087 Approximate amount paid to acquire the reported GLQ common shares

Sole voting power 0 shares Sole voting power reported by each reporting person

Shared voting power 881,942 shares Shared voting power over GLQ shares reported by each reporting person

Event date June 2, 2026 Date of event requiring this Schedule 13D amendment

Key Terms

Schedule 13D/A, beneficial owner, margin account borrowings, shared voting power, +2 more

6 terms

Schedule 13D/A regulatory

"This Amendment No. 3 amends Items 3, 5, and 7."

A Schedule 13D/A is an amended disclosure filed with regulators by an investor who already reported owning more than 5% of a company’s shares and needs to update their original filing. Think of it as a public status update that tells markets whether the investor’s ownership, plans, or source of funds have changed; such updates matter because they can signal a push for control, major strategic moves, or increased pressure on management, which can affect stock prices.

beneficial owner financial

"the beneficial owner of the Common Shares reported herein."

A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.

margin account borrowings financial

"and margin account borrowings made in the ordinary course of business."

shared voting power financial

"Shared Voting Power 881,942.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power financial

"Shared Dispositive Power 881,942.00"

aggregate amount beneficially owned financial

"Aggregate amount beneficially owned by each reporting person 881,942.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Saba Capital hold in Clough Global Equity Fund (GLQ)?

Saba Capital reports beneficial ownership of 881,942 Clough Global Equity Fund common shares, representing 4.71% of outstanding shares. This percentage is calculated using 18,738,120.892 shares outstanding as of May 8, 2026, from the fund’s DEF 14A proxy statement.

How much did Saba Capital pay for its GLQ position?

Saba Capital states it paid a total of approximately $8,818,087 to acquire the Clough Global Equity Fund shares reported. The funds came from investor subscription proceeds, related capital appreciation, and ordinary-course margin borrowings secured by securities held in margin accounts.

What voting and dispositive power does Saba have over GLQ shares?

The reporting persons show zero sole voting or dispositive power and 881,942 shares of shared voting and shared dispositive power. This means voting and sale decisions for the entire reported stake are shared among the reporting entities rather than controlled individually.

How was the 4.71% ownership percentage in GLQ calculated?

The 4.71% figure is based on 18,738,120.892 Clough Global Equity Fund common shares outstanding as of May 8, 2026. That outstanding share count comes from the company’s DEF 14A filed May 18, 2026, and is used as the denominator in the ownership calculation.

What is the purpose of Saba Capital’s transaction in GLQ according to this filing?

Item 4, which covers the purpose of the transaction, is marked not applicable in this amendment. The filing does not describe any specific plans or proposals regarding control, strategy, or governance of Clough Global Equity Fund tied to the reported ownership stake.

How did Saba Capital execute its recent GLQ trades?

The filing states that all transactions in Clough Global Equity Fund common shares from the previous amendment on May 8, 2026, through June 2, 2026 were effected in the open market. Specific trade details are provided in Schedule A, which is incorporated by reference as an exhibit.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/04/2026 - 03:52 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 3)

Clough Global Equity Fund

(Name of Issuer)

Common Shares, par value $0.001

(Title of Class of Securities)

18914C100

(CUSIP Number)

Saba Capital Management, L.P.
405 Lexington Avenue, 58th Floor, Attention: Michael D'Angelo
New York, NY, 10174
(212) 542-4635

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

06/02/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

schemaVersion:

SCHEDULE 13D

CUSIP Number(s): 18914C100

1

Name of reporting person

Saba Capital Management, L.P.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 881,942.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 881,942.00

11

Aggregate amount beneficially owned by each reporting person

881,942.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

4.71 %

14

Type of Reporting Person (See Instructions)

PN, IA

Comment for Type of Reporting Person:

The percentages used herein are calculated based upon 18,738,120.892 shares of common stock outstanding as of 5/8/26, as disclosed in the company's DEF 14A filed 5/18/26.

SCHEDULE 13D

CUSIP Number(s): 18914C100

1

Name of reporting person

Boaz R. Weinstein

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

NEW YORK

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 881,942.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 881,942.00

11

Aggregate amount beneficially owned by each reporting person

881,942.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

4.71 %

14

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person:

The percentages used herein are calculated based upon 18,738,120.892 shares of common stock outstanding as of 5/8/26, as disclosed in the company's DEF 14A filed 5/18/26.

SCHEDULE 13D

CUSIP Number(s): 18914C100

1

Name of reporting person

Saba Capital Management GP, LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 881,942.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 881,942.00

11

Aggregate amount beneficially owned by each reporting person

881,942.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

4.71 %

14

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person:

The percentages used herein are calculated based upon 18,738,120.892 shares of common stock outstanding as of 5/8/26, as disclosed in the company's DEF 14A filed 5/18/26.

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Common Shares, par value $0.001
(b)	Name of Issuer: Clough Global Equity Fund
(c)	Address of Issuer's Principal Executive Offices: 1700 Broadway, Suite 1850, Denver, COLORADO , 80290.
Item 1 Comment: This Amendment No. 3 amends Items 3, 5, and 7.
Item 2.	Identity and Background
(a)	This Schedule 13D/A is being jointly filed by: (i) Saba Capital Management, L.P., a Delaware limited partnership ("Saba Capital"); (ii) Saba Capital Management GP, LLC, a Delaware limited liability company ("Saba GP"); and (iii) Mr. Boaz R. Weinstein ("Mr. Weinstein"), (together, the "Reporting Persons"). Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party. The filing of this statement should not be construed as an admission that any Reporting Person is, for the purposes of Sections 13 of the Securities Exchange Act of 1934, the beneficial owner of the Common Shares reported herein.
(b)	The address of the business office of each of the Reporting Persons is 405 Lexington Avenue, 58th Floor, New York, New York 10174.
(c)	The principal business of: (i) Saba Capital is to serve as investment manager to private and public investment funds and/or accounts, (ii) Saba GP is to serve as general partner of the Saba Capital and other affiliated entities, and (iii) Mr. Weinstein, an individual, is managing member of the general partner of Saba Capital and other affiliated entities.
(d)	The Reporting Persons have not, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
(e)	The Reporting Persons have not, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and, as a result of such proceeding, was, or is subject to, a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or State securities laws or finding any violation with respect to such laws.
(f)	Saba Capital is organized as a limited partnership under the laws of the State of Delaware. Saba GP is organized as a limited liability company under the laws of the State of Delaware. Mr. Weinstein is a citizen of the United States.
Item 3.	Source and Amount of Funds or Other Consideration
	Funds for the purchase of the Common Shares were derived from the subscription proceeds from investors and the capital appreciation thereon and margin account borrowings made in the ordinary course of business. In such instances, the positions held in the margin accounts are pledged as collateral security for the repayment of debit balances in the account, which may exist from time to time. Since other securities are held in the margin accounts, it is not possible to determine the amounts, if any, of margin used to purchase the Common Shares reported herein. A total of approximately $8,818,087 was paid to acquire the Common Shares reported herein.
Item 4.	Purpose of Transaction
	Not Applicable.
Item 5.	Interest in Securities of the Issuer
(a)	See the Reporting Persons section of this Schedule 13D for the aggregate number of Common Shares and percentages of the Common Shares beneficially owned by each of the Reporting Persons. The percentages used herein are calculated based upon 18,738,120.892 shares of common stock outstanding as of 5/8/26, as disclosed in the company's DEF 14A filed 5/18/26.
(b)	See the Reporting Persons section of this Schedule 13D for the number of Common Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition.
(c)	The transactions in the Common Shares effected from the filing of the Schedule 13D/A on 5/8/26 by the Reporting Persons to 6/2/26, the date of the event which required filing of this Schedule 13D/A are set forth in Schedule A, and are incorporated herein by reference. All trades were effected in the open market.
(d)	The funds and accounts advised by Saba Capital have the right to receive the dividends and proceeds of sales from the Common Shares.
(e)	Jun-02-2026
Item 6.	Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
	Not Applicable.
Item 7.	Material to be Filed as Exhibits.
	Exhibit 5 - Schedule A

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Saba Capital Management, L.P.

Signature:	/s/ Michael D'Angelo
Name/Title:	General Counsel
Date:	06/04/2026

Boaz R. Weinstein

Signature:	/s/ Michael D'Angelo
Name/Title:	Authorized Signatory
Date:	06/04/2026

Saba Capital Management GP, LLC

Signature:	/s/ Michael D'Angelo
Name/Title:	Attorney-in-fact*
Date:	06/04/2026

Comments accompanying signature:

Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823